KVV09001
Colorimetric
Plasma, Serum
Quantitative (Sandwich)
15.63 - 1,000 pg/mL
8.72 pg/mL
CV<20%
80-120%
2-8 ℃
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
E6, Protein E6
Evaluating HPV E6/E7 mRNA expression and genotype prevalence in cervical cytology and biopsy samples from Yunnan Province, China., PMID:40496315
Development of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides., PMID:40476553
Crosstalk Between the Oncoproteins of High-Risk Human Papillomaviruses Types 16 and 18 in Colorectal Cancer Cell Models., PMID:40468102
Innovative nomogram for cervical cancer prediction: integrating high-risk HPV infection, p53 genotype, and blood routine parameters., PMID:40463873
Investigation of HPV DNA, in-silico validation and role of E6 protein in colorectal carcinogenesis., PMID:40435002
Molecular Insights into HPV-Driven Cervical Cancer: Oncoproteins, Immune Evasion, and Epigenetic Modifications., PMID:40431173
Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies., PMID:40403026
Human papillomavirus E1 proteins inhibit RIG-I/MDA5-MAVS, TLR3-TRIF, cGAS-STING, and JAK-STAT signaling pathways to evade innate antiviral immunity., PMID:40330484
Human papilloma virus (HPV) mediated cancers: an insightful update., PMID:40301924
Human papillomavirus E2 proteins suppress innate antiviral signaling pathways., PMID:40264759
Unlocking the secrets: Exploring the connection between HPV and bladder cancer in Pakistan., PMID:40240277
Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma virus in Bahir Dar, Amhara Regional State, Ethiopia., PMID:40238760
Astragalin inhibits the proliferation of high-risk HPV-positive cervical epithelial cells and attenuates malignant cervical lesions., PMID:40124127
Recent update on the development of HPV16 inhibitors for cervical cancer., PMID:40107437
Drosophila model of HPV18-Induced pathogenesis reveals a role for E6 oncogene in regulation of NF-κB and Wnt to inhibit apoptosis., PMID:40074036
Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer., PMID:39815804
Molecular analysis of HPV16 and HPV18 oncogenes in oral squamous cell carcinoma: Structural, transcriptomic and in vitro insights., PMID:39807101
DARPin-induced reactivation of p53 in HPV-positive cells., PMID:39789211
Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation., PMID:39761277
Comparative efficacy of HPV 16/18 DNA and E6/E7 mRNA testing in detecting high-grade cervical lesions (CIN2+) in women with cervical biopsies., PMID:39733635
Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methods., PMID:39722048
Regulation of human papillomavirus E6 oncoprotein function via a novel ubiquitin ligase FBXO4., PMID:39688415
Genome-Wide Analysis of p53 Targets Reveals SCN2A as a Novel Player in p53-Induced Cell Arrest in HPV-Positive Cells., PMID:39599840
[A fluorescence immunochromatography method for detection of human papillomavirus type 16 E6 and L1 proteins]., PMID:39584350
The Expressions of p16, HPV16-L1 and HPV18-E6 in Salivary Gland Tumours., PMID:39559137
The Distribution of HR-HPV E6/E7 DNA and mRNA by Histological Grade and the Clinical Performance for Detection of Cervical Cancer and Precancer., PMID:39540331
The anti-tumor efficacy of a recombinant oncolytic herpes simplex virus mediated CRISPR/Cas9 delivery targeting in HPV16-positive cervical cancer., PMID:39536909
Detection of transcriptionally active high-risk human papillomavirus in patients with oesophageal carcinoma by real-time PCR., PMID:39412909
Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells., PMID:39411320
Human Papillomaviruses 16 and 18 E6 Oncoprotein Detection Test in Primary Oropharyngeal Carcinomas and Metastatic Lymph Nodes: A Cross-Sectional Study., PMID:39404976
PRMT1 Modulates Alternative Splicing to Enhance HPV18 mRNA Stability and Promote the Establishment of Infection., PMID:39386465
Molecular detection of high-risk papillomaviruses and vaccination status in normal cytology in Congo., PMID:39361924
Signaling pathways in HPV-induced cervical cancer: Exploring the therapeutic promise of RNA modulation., PMID:39357186
Microfluid biosensor for detection of hpv in patient scraping samples: Determining E6 and E7 oncogenes., PMID:39146929
HPV18 E6/E7 activates Ca2+ influx to promote the malignant progression of cervical cancer by inhibiting Ca2+ binding protein 1 expression., PMID:39113388
Immunoinformatics approach for design novel multi-epitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer., PMID:39039819
Molecular Actions of Enicostemma hyssopifolium Whole Plant Extract on HPV18-Infected Human Cervical Cancer (HeLa) Cells., PMID:38982697
Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers., PMID:38978164
Genetic variability of human papillomavirus type 18 based on E6, E7 and L1 genes in central China., PMID:38970084
Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells., PMID:38967656
Quantification of HPV16 E7 Oncoproteins in Urine Specimens from Women with Cervical Intraepithelial Neoplasia., PMID:38930587
Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management., PMID:38884391
HPV-18 E6 enhances the interaction between EMILIN2 and SNX27 to promote WNT signaling., PMID:38874360
Small molecule NMD and MDM2 inhibitors synergistically trigger apoptosis in HeLa cells., PMID:38871298
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector., PMID:38858404
Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies., PMID:38715363
In vitro study of HPV18-positive cervical cancer HeLa cells based on CRISPR/Cas13a system., PMID:38710293
An Evaluation of High-Risk HPV in Squamous Cell Carcinomas of the Lip in a South African Cohort., PMID:38709462
HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer., PMID:38624210
Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18., PMID:38622605
Order: order@antibodysystem.com
Mail: support@antibodysystem.com
For research use only. Not for human or drug use.
Find out more about placing an order here
